| Literature DB >> 35722547 |
Lourdes P Dale1, Jacek Kolacz2,3, Jennifer Mazmanyan4, Kalie G Leon5, Karli Johonnot4, Nadia Bossemeyer Biernacki5, Stephen W Porges2,6.
Abstract
Childhood maltreatment history may influence autonomic reactivity and recovery to stressors. Hypothetically, the maltreatment history may contribute to a retuned autonomic nervous system that is reflected in a novel metric, vagal efficiency (VE), designed to assess the functional efficiency of vagal cardioinhibitory pathways on heart rate. We explored whether VE mediates the well-documented relationship between maltreatment history and psychiatric symptoms. We also investigated the relationship between measures of autonomic regulation in response to the physical and emotional challenges and psychiatric symptoms. Participants (n = 167) completed self-report measures of psychiatric symptoms and had continuous beat-to-beat heart rate monitored before, during, and after physical and emotional stressors. Participants with maltreatment histories exhibited lower VE, which mediated the association of maltreatment history and the psychiatric symptoms of anxiety and depression. Consistent with prior literature, there were significant associations between maltreatment history and autonomic reactivity (i.e., heart rate and respiratory sinus arrhythmia) during emotional and physical challenges; however, when VE was entered as a covariate these associations were no longer statistically significant. Blunted VE may reflect a neural pathway through which maltreatment retunes autonomic regulation and provides a neurophysiological platform that increases mental health risk.Entities:
Keywords: PTSD; Polyvagal Theory; heart rate variability; maltreatment; respiratory sinus arrhythmia; vagal efficiency
Year: 2022 PMID: 35722547 PMCID: PMC9201111 DOI: 10.3389/fpsyt.2022.841749
Source DB: PubMed Journal: Front Psychiatry ISSN: 1664-0640 Impact factor: 5.435
Descriptive statistics for RSA and HP.
| RSA | HP | |||||
| Variable |
| Min | Max |
| Min | Max |
| Baseline | 7.18 (1.14) | 3.55 | 9.78 | 861.60 (143.52) | 544.00 | 1320.68 |
|
| ||||||
| Reactivity | −4.52 (1.63) | −8.78 | 0.02 | −370.17 (130.09) | −873.67 | −82.43 |
| Recovery | 3.48 (1.43) | 0.40 | 6.99 | 222.55 (105.24) | 47.46 | 561.59 |
|
| ||||||
| Reactivity | −0.02 (0.90) | −4.95 | 3.52 | 40.32 (60.06) | −271.83 | 245.03 |
| Recovery | 0.09 (0.63) | −1.55 | 3.11 | −9.78 (58.54) | −180.16 | 480.88 |
FIGURE 1An illustration of vagal efficiency (VE) during baseline, biking, and recovery. Data is displayed for 2 participants: one with high VE (top row) and one with low VE (bottom row). Figures in the left column show cardiac vagal tone [measured by respiratory sinus arrhythmia (RSA); dotted line] and HP (solid line) over the course of the protocol. The participant in the top row has strong coupling between RSA and HP, which can also be seen in the steep slope between synchronous observations in the top right figure (slope = 114.14). The top right plot reflects the participants’ rapid shift from high RSA/high HP during baseline and recovery relative to low RSA/low HP states during physical exercise. These data suggest a rapid withdrawal and re-engagement of the vagal brake to regulate metabolic demands. The participant in the bottom panel had similar ranges of RSA values, but RSA was weakly associated with HP (slope = 59.30), suggesting that cardioinhibitory vagal influences were not efficient in slowing cardiac metabolic output.
Comparison of maltreatment and no maltreatment groups.
| Maltreatment group | No maltreatment group |
|
|
| |||||
| 95% CI | 95% CI | ||||||||
| Lower | Upper | Lower | Upper | ||||||
| Vagal efficiency | 61.70 (19.48) | 57.40 | 66.01 | 69.56 (25.54) | 0.35 | 75.70 | − |
| 0.37 |
| Baseline RSA | 6.97 (1.23) | 6.69 | 7.24 | 7.38 (1.02) | 0.37 | 7.60 | − |
| 0.38 |
| Baseline HP | 831.70 (136.80) | 801.45 | 861.95 | 888.79 (145.35) | 0.40 | 920.14 | − |
| 0.42 |
|
| |||||||||
| RSA reactivity | −4.71 (1.53) | −0.5.04 | −4.37 | −4.38 (1.68) | 0.21 | −4.01 | −1.32 | 0.190 | 0.21 |
| HP reactivity | −357.62 (129.28) | −386.20 | −329.03 | −382.68 (131.17) | −0.19 | −354.22 | 1.24 | 0.218 | −0.22 |
| RSA recovery | 3.47 (1.35) | 3.18 | 3.77 | 3.51 (1.49) | 0.03 | 3.84 | −0.18 | 0.859 | 0.01 |
| HP recovery | 198.96 (96.70) | 177.58 | 220.34 | 244.11 (108.96) | 0.44 | 267.76 | − |
| 0.45 |
|
| |||||||||
| RSA reactivity | 0.11 (0.90) | −0.09 | 0.31 | −0.13 (0.90) | −0.27 | 0.06 | 1.72 | 0.087 | −0.41 |
| HP reactivity | 32.78 (64.79) | 18.45 | 47.11 | 49.06 (52.98) | 0.28 | 60.56 | −1.77 | 0.079 | 0.25 |
| RSA recovery | 0.01 (0.53) | −0.11 | 0.14 | 0.16 (0.70) | 0.24 | 0.32 | −1.50 | 0.136 | 0.19 |
| HP recovery | −5.45 (40.00) | −14.41 | 3.51 | −14.67 (71.80) | −0.29 | 1.01 | 1.00 | 0.318 | −0.29 |
|
| |||||||||
| Somatization | 3.85 (4.13) | 2.94 | 4.76 | 2.37 (2.62) | 0.43 | 2.94 |
|
| −0.43 |
| Depression | 5.77 (5.10) | 4.64 | 6.89 | 3.16 (3.90) | 0.57 | 4.02 |
|
| −0.57 |
| Anxiety | 5.94 (4.97) | 4.84 | 7.04 | 3.59 (4.05) | 0.52 | 4.46 |
|
| −0.53 |
| PTSD | 34.78 (13.28) | 31.82 | 37.73 | 27.22 (9.40) | 0.66 | 29.25 |
|
| −0.53 |
D = Cohen’s d. Bold values indicate significant group differences (p < 0.05).
Correlation among physiological measures and symptomatology.
| Somatization symptoms | Depression symptoms | Anxiety symptoms | PTSD symptoms | |
| Vagal efficiency | –0.05 | −0.16 | −0.17 | –0.10 |
|
| ||||
| Baseline RSA | 0.01 | 0.05 | –0.05 | 0.09 |
| Baseline HP | –0.09 | –0.15 | −0.20 | –0.12 |
|
| ||||
| RSA reactivity | –0.02 | –0.05 | –0.03 | –0.05 |
| HP Reactivity | 0.07 | 0.13 | 0.13 | 0.12 |
| RSA recovery | –0.01 | 0.00 | 0.02 | 0.10 |
| HP recovery | −0.18 | −0.17 | −0.21 | –0.11 |
|
| ||||
| RSA reactivity | 0.07 | 0.09 | 0.09 | 0.10 |
| HP reactivity | −0.16 | −0.19 | −0.24 | −0.17 |
| RSA recovery | 0.02 | –0.11 | –0.09 | –0.08 |
| HP recovery | 0.01 | 0.05 | 0.03 | –0.03 |
*p < 0.05, **p < 0.01.
FIGURE 2Effects of childhood maltreatment on depression and anxiety as mediated by vagal efficiency. Note that in the top figures, first numbers represent path estimates and parentheses reflect standard errors, with significant paths marked with *. Partial mediation was supported by a non-zero indirect effects. In the bottom figures are density plots of VE and depression and anxiety symptoms, with lighter colors indicating higher density of observations and darker colors representing fewer observations. The modal tendency of the maltreatment sample skews left indicating poorer VE and upward indicating higher depression and anxiety symptomatology compared to the non-maltreated sample on the left.
TableCorrelations among physiological variables.
| Physical stressor | Emotional stressor | |||||||
| Reactivity | Recovery | Reactivity | Recovery | |||||
| RSA | HP | RSA | HP | RSA | HP | RSA | HP | |
| Vagal efficiency | 0.15 | −0.51 | –0.10 | 0.48 | –0.03 | 0.07 | 0.04 | 0.04 |
|
| ||||||||
| RSA reactivity | 0.45 | −0.45 | 0.15 | −0.26 | –0.14 | 0.16 | –0.03 | |
| HP reactivity | −0.35 | −0.45 | 0.06 | −0.21 | −0.16 | 0.05 | ||
| RSA recovery | 0.48 | –0.09 | 0.04 | −0.16 | –0.09 | |||
| HP recovery | −0.34 | 0.00 | 0.06 | –0.14 | ||||
|
| ||||||||
| RSA reactivity | 0.42 | −0.46 | –0.10 | |||||
| HP reactivity | –0.08 | −0.41 | ||||||
| RSA recovery | 0.40 | |||||||
Vagal efficiency was calculated for the physical stressor.
*p < 0.05, **p < 0.01, ***p < 0.001.
FIGURE 3Results of repeated measures analyses of variance documenting changes in respiratory sinus arrhythmia (RSA) and heart period (HP) in response to the physical stressor (i.e., riding a stationary bike) and the emotional stressor (i.e., viewing a video of a child being maltreated) as a function of maltreatment history.
Repeated measures ANOVA comparison of heart period regulation for the psychiatric symptom clinical cutoff groups.
| Psychiatric symptom groups | Main effects for psychiatric groups and group × HP interaction effects | Without covariate | VE as Covariate | ||||
|
|
| η2 |
|
| η2 | ||
|
| |||||||
| Somatization | Group main effect | 4.35 | 0.039 | 0.026 | 3.57 | 0.061 | 0.021 |
| Interaction effect | 3.78 | 025 | 0.044 | 3.34 | 0.038 | 0.039 | |
| Depression | Group main effect | 4.52 | 0.035 | 0.027 | 2.15 | 0.144 | 0.013 |
| Interaction effect | 3.90 | 0.022 | 0.045 | 2.68 | 0.072 | 0.032 | |
| Anxiety | Group main effect | 9.21 | 0.003 | 0.053 | 2.49 | 0.116 | 0.015 |
| Interaction effect | 4.67 | 0.011 | 0.054 | 1.58 | 0.208 | 0.019 | |
| PTSD | Group main effect | 5.06 | 0.026 | 0.030 | 1.96 | 0.163 | 0.012 |
| Interaction | 3.40 | 0.036 | 0.040 | 1.83 | 0.165 | 0.022 | |
|
| |||||||
| Somatization | Group main effect | 3.17 | 0.077 | 0.019 | 2.18 | 0.142 | 0.013 |
| Interaction effect | 1.74 | 0.178 | 0.021 | 1.62 | 0.201 | 0.020 | |
| Depression | Group main effect | 4.24 | 0.041 | 0.026 | 2.29 | 0.133 | 0.014 |
| Interaction effect | 3.73 | 0.028 | 0.044 | 3.41 | 0.036 | 0.041 | |
| Anxiety | Group main effect | 7.46 | 0.007 | 0.044 | 1.64 | 0.203 | 0.010 |
| Interaction effect | 4.95 | 0.008 | 0.058 | 4.48 | 0.013 | 0.053 | |
| PTSD | Group main effect | 5.31 | 0.022 | 0.032 | 2.66 | 0.105 | 0.016 |
| Interaction effect | 3.81 | 0.024 | 0.046 | 3.53 | 0.032 | 0.043 | |